| Collaborations |
|
Athersys, Inc.
A joint venture to develop and commercialize a specific therapeutic protein. Athersys is contributing the protein production capabilities of its RAGE technology and Elan is contributing a proprietary drug delivery technology.
|
|
Norseman, Inc.
Strategic Partnership - Web based Digital Document Delivery software
|
|
Neurome, Inc.
The research partnership with Elan has an initial term of 3 years and may generate up to $4 million in service revenue for Neurome, together with shared ownership of the diagnostic and therapeutic applications of the genes, circuits and mechanisms identified in the research. The partnership will utilize Neurome's technologies to analyze a mouse model of Alzheimer's Disease with the goal of identifying and exploiting molecules and pathways relevant to diagnosis and treatment of the disease. The partnership will analyze Elan's proprietary mouse model of amyloid deposition in an attempt to answer a variety of scientific questions regarding amyloid deposition.
|
|
Biogen Idec, Inc. (Massachusetts)
(crohn's & MS)
|
|
Digital Gene Technologies
Alzheimer's Disease, Parkinson's Disease, novel mechanisms for drug delivery
|
|
RxKinetix, Inc.
Joint venture for the treatment of oral mucositis
|
|
NewBiotics, Inc.
|
|
Antigenics Inc. (New York)
|